Condition: Essential Hypertension · Sponsor: Lepu Medical Technology (Beijing) Co., Ltd.
This is a prospective, multicenter, blinded, randomized controlled clinical trial designed to evaluate the safety and efficacy of a single-use intravascular ultrasound ablation catheter and ultrasound ablation system in the treatment of primary hypertension.
This description comes directly from the study's public registry record.
Contact details are listed per location below or on the registry record.
Always discuss trial participation with your own doctor first.
| Beijing Anzhen hospital , Capital Medical University | Beijing, Beijing Municipality, China | Recruiting |
| China-Japan Friendship Hospital | Beijing, Beijing Municipality, China | Recruiting |
| Peking University First Hospital | Beijing, Beijing Municipality, China | Not Yet Recruiting |
| Beijing Jishuitan Hospital Affiliated to Capital Medical University | Beijing, Beijing Municipality, China | Recruiting |
| Beijing Tsinghua Changgung Hospital | Beijing, Beijing Municipality, China | Recruiting |
| The Second Affiliated Hospital Chongqing Medical University | Chongqing, Chongqing Municipality, China | Recruiting |
| The First Affiliated Hospital of Xiamen University | Xiamen, Fujian, China | Not Yet Recruiting |
| The Second Hospital of Lanzhou University | Lanzhou, Gansu, China | Recruiting |
| Shenzhen University General Hospital | Shenzhen, Guangdong, China | Not Yet Recruiting |
| Henan Provincial People's Hospital | Zhengzhou, Henan, China | Recruiting |
| Inner Mongolia People's Hospital | Hohhot, Neimenggu, China | Recruiting |
| Yinchuan First People's Hospital | Yinchuan, Ningxia, China | Recruiting |
+ 6 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07051811